Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wessler

Showing results (511-520 of 523) with videos related to

Pageof 53
Sort By:
Metabolic Brain Disease|April 30, 2015
Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophreniaAlexandra Ioppi Zugno, Felipe Damázio Pacheco, Josiane Budni, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Evolution of plant cell-type-specific cis-regulatory elementsHaidong Yan, John P Mendieta, Xuan Zhang, et al.
Life Sciences|December 16, 2014
Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophreniaAlexandra I Zugno, Helder Chipindo, Lara Canever, et al.
Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Journal of Psychiatric Research|July 2, 2016
Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamineAlexandra I Zugno, Lara Canever, Alexandra S Heylmann, et al.
Neuroscience|December 10, 2013
Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophreniaA I Zugno, H L Chipindo, A M Volpato, et al.
BMC Family Practice|May 22, 2020
Practice facilitation to promote evidence-based screening and management of unhealthy alcohol use in primary care: a practice-level randomized controlled trialAlison N Huffstetler, Anton J Kuzel, Roy T Sabo, et al.
Nature Plants|September 17, 2025
A single-cell rice atlas integrates multi-species data to reveal cis-regulatory evolutionHaidong Yan, John P Mendieta, Xuan Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEGMorgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
JACC. Advances|March 24, 2026
Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline StudyMellanie True Hills, Serge Korjian, Gerald Chi, et al.
Pageof 53

Showing results (511-520 of 523) with videos related to

Sort By:
Pageof 53
Metabolic Brain Disease|April 30, 2015
Maternal deprivation disrupts mitochondrial energy homeostasis in the brain of rats subjected to ketamine-induced schizophreniaAlexandra Ioppi Zugno, Felipe Damázio Pacheco, Josiane Budni, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Evolution of plant cell-type-specific cis-regulatory elementsHaidong Yan, John P Mendieta, Xuan Zhang, et al.
Life Sciences|December 16, 2014
Omega-3 fatty acids prevent the ketamine-induced increase in acetylcholinesterase activity in an animal model of schizophreniaAlexandra I Zugno, Helder Chipindo, Lara Canever, et al.
Circulation. Cardiovascular Imaging|November 12, 2013
Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism databaseBenjamin S Wessler, David E Thaler, Robin Ruthazer, et al.
Journal of Psychiatric Research|July 2, 2016
Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamineAlexandra I Zugno, Lara Canever, Alexandra S Heylmann, et al.
Neuroscience|December 10, 2013
Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophreniaA I Zugno, H L Chipindo, A M Volpato, et al.
BMC Family Practice|May 22, 2020
Practice facilitation to promote evidence-based screening and management of unhealthy alcohol use in primary care: a practice-level randomized controlled trialAlison N Huffstetler, Anton J Kuzel, Roy T Sabo, et al.
Nature Plants|September 17, 2025
A single-cell rice atlas integrates multi-species data to reveal cis-regulatory evolutionHaidong Yan, John P Mendieta, Xuan Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 28, 2019
Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEGMorgan D McSweeney, Lauren S L Price, Timothy Wessler, et al.
JACC. Advances|March 24, 2026
Direct-to-Participant Enrollment in a Virtual Trial: Lessons Learned From the Heartline StudyMellanie True Hills, Serge Korjian, Gerald Chi, et al.
Pageof 53